跳至主要内容
临床试验/NCT04184999
NCT04184999已完成4 期

Evaluation of Intraoperative Use of Dexycu on the Signs and Symptoms of Dry Eye

SR Cornea Consultants1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年8月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Evaluation of Intraoperative Use of Dexycu on Tear Film Osmolarity at 3 Weeks Postoperatively

研究概览

简要总结

To compare the signs and symptoms of dry eye after cataract surgery between subjects randomized to receive intraoperative dexamethasone in addition to the use of a standard topical post-op treatment regimen.

详细描述

Forty patients requiring cataract surgery will be randomized to treatment of post-operative inflammation with a single intraoperative dexamethasone injection plus a standard course of topical ophthalmic corticosteroid drops or the standard treatment alone. Dry eye testing will be administered at baseline, 1 week and 3 weeks following surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • undergoing bilateral cataract surgery

排除标准

  • central corneal staining with fluorescein and/or a tear film osmolarity of greater than 340 in either eye

研究组 & 干预措施

Intracameral dexamethasone 9% + postoperative topical prednisolone acetate

Experimental

dexamethasone intraocular suspension, 9% injected intracamerally at the time of cataract surgery + topical ophthalmic prednisolone acetate for 3 weeks post-operatively

干预措施: dexamethasone intraocular suspension, 9% (Drug)

Intracameral dexamethasone 9% + postoperative topical prednisolone acetate

Experimental

dexamethasone intraocular suspension, 9% injected intracamerally at the time of cataract surgery + topical ophthalmic prednisolone acetate for 3 weeks post-operatively

干预措施: Prednisolone Acetate 1% Oph Susp (Drug)

postoperative topical prednisolone acetate

Active Comparator

topical ophthalmic prednisolone acetate for 3 weeks post-operatively

干预措施: Prednisolone Acetate 1% Oph Susp (Drug)

结局指标

主要结局

Evaluation of Intraoperative Use of Dexycu on Tear Film Osmolarity at 3 Weeks Postoperatively

时间窗: 3 weeks

Tear Film Osmolarity as measured on Tear Lab system; validated measure of Tear Film Osmolarity Osmolarity was reported in milliosmoles per liter (mOsmol/L)

次要结局

未报告次要终点

研究者

发起方
SR Cornea Consultants
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sanjay N Rao, MD

Principal Investigator

SR Cornea Consultants

研究点 (1)

Loading locations...

相似试验